
News|Articles|December 16, 2025
Process Optimization for High Purity mAb Recovery
Author(s)Tosoh Bioscience
Now more than ever, researchers are leveraging the power of monoclonal antibodies (mAbs) to fight life-threatening diseases. To support scientists worldwide in their purification efforts, this Application Note details an example workflow to optimizing purification steps for mAb capture, the most critical step in downstream bioprocessing, using a novel protein A resin.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
WHO Finalizes United States’ Withdrawal from Organization: Report
4
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
5